Literature DB >> 33797746

Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus.

Cem Süer1, Nurbanu Yıldız1, Özlem Barutçu1, Burak Tan2, Nurcan Dursun3.   

Abstract

BACKGROUND: The present study examined whether inhibition of guanylate cyclase (GC) is associated with the plasticity-related microtubule-stabilizing protein tau phosphorylation in the dentate gyrus (DG) of hippocampal formation.
METHODS: To address this issue, methylene blue (MB 50 μM) or saline was infused into the DG starting from the induction of long-term potentiation (LTP) or depression (LTD) for 1 h. Then, protein phosphatase 1 alpha (PP1α), glycogen synthase kinase 3 beta (GSK3β), and tau total and phosphorylated protein levels were measured in these hippocampi using western blotting. LTP and LTD were induced by application of high- and low-frequency stimulation protocols (HFS and LFS), respectively. 5-min averages of the excitatory postsynaptic potential (EPSP) slopes and population spike amplitudes at the end of recording were averaged to measure the magnitude of LTP or LTD.
RESULTS: Low-frequency stimulation protocols was unable to phosphorylate thr181 and thr231epitopes of tau, but possessed kinase activity similar to the HFS in phosphorylation of ser396 and ser416 epitopes. MB infusion during LTD induction attenuated LTD, prevented EPSP/spike dissociation and increased tau phosphorylation at ser396 and ser416 epitopes, without changing tau phosphorylation at thr181 and thr231 epitopes. Neither LTP nor LTP-related tau phosphorylation state was changed by MB infusion.
CONCLUSION: Although MB can benefit to stabilize the balance between LTP and LTD, and to fix the increased spike wave discharges, it might trigger deregulation of tau phosphorylation, leading to the development of Alzheimer's disease by a mechanism that goes awry during induction of LTD. Thereby detailed studies to reveal more precise evidence for the use of MB in this disease are needed.

Entities:  

Keywords:  Alzheimer disease; Hippocampus; Long-term depression; Long-term potentiation; Methylene blue

Mesh:

Substances:

Year:  2021        PMID: 33797746     DOI: 10.1007/s43440-021-00254-y

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  62 in total

1.  Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.

Authors:  Erik D Roberson; Brian Halabisky; Jong W Yoo; Jinghua Yao; Jeannie Chin; Fengrong Yan; Tiffany Wu; Patricia Hamto; Nino Devidze; Gui-Qiu Yu; Jorge J Palop; Jeffrey L Noebels; Lennart Mucke
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

2.  Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers.

Authors:  Marie Lise Frandemiche; Sandrine De Seranno; Travis Rush; Eve Borel; Auréliane Elie; Isabelle Arnal; Fabien Lanté; Alain Buisson
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

3.  Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity.

Authors:  H K Lee; M Barbarosie; K Kameyama; M F Bear; R L Huganir
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

4.  Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.

Authors:  Arne Ittner; Sook Wern Chua; Josefine Bertz; Alexander Volkerling; Julia van der Hoven; Amadeus Gladbach; Magdalena Przybyla; Mian Bi; Annika van Hummel; Claire H Stevens; Stefania Ippati; Lisa S Suh; Alexander Macmillan; Greg Sutherland; Jillian J Kril; Ana P G Silva; Joel P Mackay; Anne Poljak; Fabien Delerue; Yazi D Ke; Lars M Ittner
Journal:  Science       Date:  2016-11-18       Impact factor: 47.728

5.  Depotentiation of Long-Term Potentiation Is Associated with Epitope-Specific Tau Hyper-/Hypophosphorylation in the Hippocampus of Adult Rats.

Authors:  Ercan Babür; Burak Tan; Sumeyra Delibaş; Marwa Yousef; Nurcan Dursun; Cem Süer
Journal:  J Mol Neurosci       Date:  2018-11-29       Impact factor: 3.444

6.  Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF.

Authors:  Qian Chen; Zhou Zhou; Lei Zhang; Yuan Wang; Yan-wen Zhang; Min Zhong; Shang-cheng Xu; Chun-hai Chen; Li Li; Zheng-ping Yu
Journal:  Neurochem Int       Date:  2011-12-31       Impact factor: 3.921

7.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation.

Authors:  Olivia A Shipton; Julie R Leitz; Jenny Dworzak; Christine E J Acton; Elizabeth M Tunbridge; Franziska Denk; Hana N Dawson; Michael P Vitek; Richard Wade-Martins; Ole Paulsen; Mariana Vargas-Caballero
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

9.  Tau phosphorylation at serine 396 residue is required for hippocampal LTD.

Authors:  Philip Regan; Thomas Piers; Jee-Hyun Yi; Dong-Hyun Kim; Seonghoo Huh; Se Jin Park; Jong Hoon Ryu; Daniel J Whitcomb; Kwangwook Cho
Journal:  J Neurosci       Date:  2015-03-25       Impact factor: 6.167

10.  Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation.

Authors:  Shunsuke Kobayashi; Toru Tanaka; Yoshiyuki Soeda; Osborne F X Almeida; Akihiko Takashima
Journal:  EBioMedicine       Date:  2017-05-17       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.